The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
U.S. federal officials have approved a new pain pill aimed at preventing addiction and overdose risks linked to opioids like ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The US Food and Drug Administration has approved suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid ...
Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...
US President Donald Trump announced significant tariffs on imports from Canada, Mexico, and China to address issues like illegal immigration and trade imbalances. Starting Saturday, 25% tariffs ...